← Back to All Filings

Natera Director Matthew Rabinowitz Files Form 144 to Sell $687K in Common Stock

Low SignificanceOctober 27, 2026 at 4:43:43 PM EDT

Natera, Inc.

$NTRA144CIK: 0001604821

Subscribe to track NTRA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📋 Form 144 Notice of Proposed Sale Company: Natera, Inc. ($NTRA) Insider: Matthew Rabinowitz (Director) Shares to Sell: 1,697 Common Stock Est. Market Value: $687,115.30 (~$404.90/share) Broker: ETrade Corporation Acquisition: Restricted Stock Units vested on 10/26/2026

Comprehensive Analysis

Executive Summary

On October 27, 2026, Matthew Rabinowitz, Director and co-founder of Natera, Inc. ($NTRA), filed a Form 144 proposing the sale of 1,697 shares of common stock with an aggregate market value of approximately $687,115.30 (~$404.90 per share). The proposed transaction is scheduled to be executed through ETrade Corporation on NASDAQ.

Transaction & Acquisition Context

  • Nature of Acquisition: The 1,697 shares being sold were acquired upon the vesting of Restricted Stock Units (RSUs) on October 26, 2026, awarded as compensation for services rendered.
  • Transaction Size: The 1,697 shares represent a negligible fraction of the company's 144,144,170 outstanding shares (approximately 0.001%). The small transaction size following an RSU vest is characteristic of routine sell-to-cover or post-vesting liquidity transactions.
  • Recent Sales Activity: Over the preceding three months, Dr. Rabinowitz has executed multiple large-scale divestments, including 200,000 shares across four separate 50,000-share sales in September and October 2026 for total proceeds exceeding $70 million, as well as smaller programmatic sales following prior RSU vestings.

Market & Trading Significance

Given the modest size of this specific filing ($687K) and its tie to an RSU vesting event on the prior day, this notice carries Low trading significance on a standalone basis.

Topics:#NTRA#Natera#Form144#InsiderTrading#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.